Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 Acta Psychiatr Scand
2 Brain Res
1 J Clin Psychopharmacol
2 Mol Psychiatry
1 Neuropsychology
1 PLoS One
1 Psychiatry Res
2 Psychol Med
9 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Psychiatr Scand

  1. DALAL TC, Liang L, Silva AM, Mackinley M, et al
    Speech based natural language profile before, during and after the onset of psychosis: A cluster analysis.
    Acta Psychiatr Scand. 2024 Apr 10. doi: 10.1111/acps.13685.
    PubMed         Abstract available

    Brain Res

  2. LIU B, Wang C, Liu R, Xiang W, et al
    Function and mechanism exploring of icariin in schizophrenia through network pharmacology.
    Brain Res. 2024 Apr 9:148931. doi: 10.1016/j.brainres.2024.148931.
    PubMed         Abstract available

  3. SMITH SS, Benanni S, Jones Q, Kenney L, et al
    Manipulation of alpha4betadelta GABA(A) receptors alters synaptic pruning in layer 3 prelimbic prefrontal cortex and impairs temporal order recognition: Implications for schizophrenia and autism.
    Brain Res. 2024 Apr 8:148929. doi: 10.1016/j.brainres.2024.148929.
    PubMed         Abstract available

    J Clin Psychopharmacol

  4. SCALA M, Martinez Trapote P, Rodriguez-Jimenez R, Pecorino B, et al
    Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient: A Case Report of a Progestin-Only Pill.
    J Clin Psychopharmacol. 2024 Apr 9. doi: 10.1097/JCP.0000000000001836.

    Mol Psychiatry

  5. TOTZEK JF, Chakravarty MM, Joober R, Malla A, et al
    Longitudinal inference of multiscale markers in psychosis: from hippocampal centrality to functional outcome.
    Mol Psychiatry. 2024 Apr 11. doi: 10.1038/s41380-024-02549.
    PubMed         Abstract available

  6. SUPEKAR K, de Los Angeles C, Ryali S, Kushan L, et al
    Robust and replicable functional brain signatures of 22q11.2 deletion syndrome and associated psychosis: a deep neural network-based multi-cohort study.
    Mol Psychiatry. 2024 Apr 12. doi: 10.1038/s41380-024-02495.
    PubMed         Abstract available


  7. WHEARTY KM, Ruiz I, Knippenberg AR, Strauss GP, et al
    Anhedonia reflects an encoding deficit for pleasant stimuli in schizophrenia: Evidence from the emotion-induced memory trade-off eye-tracking paradigm.
    Neuropsychology. 2024 Apr 11. doi: 10.1037/neu0000908.
    PubMed         Abstract available

    PLoS One

  8. BASU A, Dutta AK, Bagepally BS, Das S, et al
    Pharmacogenomics-assisted schizophrenia management: A hybrid type 2 effectiveness-implementation study protocol to compare the clinical utility, cost-effectiveness, and barriers.
    PLoS One. 2024;19:e0300511.
    PubMed         Abstract available

    Psychiatry Res

  9. SPINAZZOLA E, Quattrone D, Quattrone A, Murray RM, et al
    The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use.
    Psychiatry Res. 2024;336:115869.

    Psychol Med

  10. UCOK A, Noyan H, Guloksuz S, Saka MC, et al
    The relationship between childhood trauma, psychotic symptoms, and cognitive schemas in patients with schizophrenia, their siblings, and healthy controls: results from the EU-GEI study.
    Psychol Med. 2024 Apr 12:1-12. doi: 10.1017/S0033291724000540.
    PubMed         Abstract available

  11. MOLINA JL, Joshi YB, Nungaray JA, Sprock J, et al
    Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia.
    Psychol Med. 2024 Apr 8:1-8. doi: 10.1017/S0033291724000783.
    PubMed         Abstract available

    Schizophr Res

  12. GOUSE BM, Oblath R, Gibbs JS, Reagan EG, et al
    COVID-19 pandemic and emergency department visits for psychosis: Visit volume, restraint use, medication use, psychiatric hospitalization, and length of stay.
    Schizophr Res. 2024;267:301-307.
    PubMed         Abstract available

  13. DIAO H, Ma J, Jia Y, Jia H, et al
    Abnormalities in motor adaptation to different types of perturbations in schizophreniaperturbations in schizophrenia.
    Schizophr Res. 2024;267:291-300.
    PubMed         Abstract available

  14. CATTARINUSSI G, Di Giorgio A, Sambataro F
    Cerebellar dysconnectivity in schizophrenia and bipolar disorder is associated with cognitive and clinical variables.
    Schizophr Res. 2024 Apr 6:S0920-9964(24)00139.
    PubMed         Abstract available

  15. HO G, Pratt DN, Bridgwater MA, Schiffman J, et al
    Factors impacting intent to seek treatment within youth at clinical high risk for psychosis.
    Schizophr Res. 2024;267:273-281.
    PubMed         Abstract available

  16. KANG MJY, Eratne D, Wannan C, Santillo AF, et al
    Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosis.
    Schizophr Res. 2024;267:269-272.
    PubMed         Abstract available

  17. SKLAR AL, Matinrazm S, Esseku A, Lopez-Caballero F, et al
    Intensity-dependent modulation of the early auditory gamma-band response in first-episode schizophrenia and its association with disease symptoms.
    Schizophr Res. 2024;267:261-268.
    PubMed         Abstract available

  18. MULLIGAN LD, Bojanic L, Hunt IM, Baird A, et al
    Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in England.
    Schizophr Res. 2024;267:254-260.
    PubMed         Abstract available

  19. KISELY S, Arnautovska U, Siskind D, Warren N, et al
    Admissions for psychosis following agency-notified child maltreatment at 40-year-follow-up: Results from the Childhood Adversity and Lifetime Morbidity (CALM) cohort.
    Schizophr Res. 2024;267:247-253.
    PubMed         Abstract available

  20. OPLER M, Negash S, Tatsumi K, Liu C, et al
    Use of a novel study insight analytics (SIA) methodology to improve PANSS data quality and signal detection in a global clinical trial in schizophrenia.
    Schizophr Res. 2024;267:239-246.

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.